Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Rumbleon Inc (NQ: RMBL )

5.160 +0.120 (+2.38%)
Streaming Delayed Price Updated: 4:00 PM EDT, Nov 1, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Rumbleon Inc

< Previous 1 2 3 4 5 6 7 Next >
RumbleON Appoints Blake Lawson As Finance Chief
Via Benzinga
RumbleOn Promotes Blake Lawson, Seasoned Powersports Executive, to Chief Financial Officer
From RumbleOn, Inc.
Via Business Wire
RumbleOn to Present at the 25th ICR Conference on January 9, 2023
From RumbleOn, Inc.
Via Business Wire
RumbleOn to Present at the Wolfe Research Consumer Growth Conference on December 6, 2022
From RumbleOn, Inc.
Via Business Wire
RumbleON Shares Soar On Q2 Earnings Beat
Via Benzinga
Recap: RumbleON Q2 Earnings
  RumbleON (NASDAQ:RMBL) reported its Q2 earnings results on Tuesday, August 9, 2022 at 07:30 AM. Here's what investors need to know about the announcement. 
Via Benzinga
RumbleON Inks Sponsorship Agreement With City Of Sturgis For Motorcycle Rally
Via Benzinga
Stocks That Hit 52-Week Lows On Monday
  On Monday, 297 companies reached new 52-week lows. 
Via Benzinga
Medtronic To $85? Plus Oppenheimer Slashes PT On This Stock By 67%
  
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 70 companies set new 52-week lows. 
Via Benzinga
Stocks That Hit 52-Week Lows On Thursday
  During Thursday's session, 97 companies made new 52-week lows. 
Via Benzinga
Why Merrimack Pharmaceuticals Shares Jumped Around 213%; Here Are 114 Biggest Movers From Yesterday
Gainers 
Via Benzinga
Stocks That Hit 52-Week Lows On Wednesday
  On Wednesday, 283 companies set new 52-week lows. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Wednesday's Intraday Session
Gainers 
Via Benzinga
Why RumbleON Shares Are Trading Higher By Around 28%? Here Are 84 Stocks Moving In Wednesday's Mid-Day Session
Gainers 
Via Benzinga
RumbleOn Reports Third Quarter 2022 Financial Results
From RumbleOn, Inc.
Via Business Wire
5 Value Stocks To Watch In The Consumer Cyclical Sector
What is a Value Stock? 
Via Benzinga
RumbleOn Announces Used Powersports Inventory Financing Credit Facility Agreement with J.P. Morgan
From RumbleOn, Inc.
Via Business Wire
RumbleOn Announces Third Quarter 2022 Earnings Release and Conference Call Schedule
From RumbleOn, Inc.
Via Business Wire
Benzinga's Top Ratings Upgrades, Downgrades For September 21, 2022
Upgrades For Berkshire Hathaway Inc (NYSE:BRK), Edward Jones upgraded the previous rating of Hold to Buy. Berkshire Hathaway earned $6312.49 in the second quarter, compared to $4399.91 in the year-ago... 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Monday's After-Market Session
Gainers Cazoo Gr (NYSE:CZOO) stock rose 8.8% to $0.68 during Monday's after-market session. The market value of their outstanding shares is at $517.3 million. 
Via Benzinga
A Look Into Consumer Cyclical Sector Value Stocks
What are Value Stocks? 
Via Benzinga
Why Avalo Therapeutics Surged 32%; Here Are 111 Biggest Movers From Yesterday
Gainers AeroClean Technologies, Inc. (NASDAQ: AERC) gained 60.1% to settle at $7.27 on Tuesday after the company was granted US patent for an air treatment system and method. 
Via Benzinga
12 Consumer Discretionary Stocks Moving In Tuesday's Intraday Session
  
Via Benzinga
Why Verona Pharma Is Trading Higher By Around 84%, Here Are 85 Stocks Moving In Tuesday's Mid-Day Session
Gainers Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD.... 
Via Benzinga
Qualys, ShockWave Medical, News Corporation And Some Other Big Stocks Moving Higher On Tuesday
  Verona Pharma plc (NASDAQ: VRNA) shares jumped 83.6% to $12.70 after the company announced ensifentrine met its primary endpoint and secondary endpoints in the Phase 3 ENHANCE-2 trial for COPD. The... 
Via Benzinga
RumbleOn Reports Record Second Quarter 2022 Financial Results
From RumbleOn, Inc.
Via Business Wire
RumbleOn Announces Second Quarter 2022 Earnings Release and Conference Call Schedule
From RumbleOn, Inc.
Via Business Wire
RumbleOn Appoints Seasoned Executive Shin Lee to its Board of Directors
From RumbleOn, Inc.
Via Business Wire
Earnings Scheduled For August 9, 2022
Companies Reporting Before The Bell • Cognition Therapeutics (NASDAQ:CGTX) is estimated to report earnings for its second quarter. 
Via Benzinga
< Previous 1 2 3 4 5 6 7 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.